ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,435,605 | +200.3% | 68,887 | +245.1% | 0.14% | +174.5% |
| Q2 2023 | $478,018 | -9.8% | 19,959 | -29.1% | 0.05% | -17.7% |
| Q1 2023 | $529,764 | +39.4% | 28,149 | +18.0% | 0.06% | +10.7% |
| Q4 2022 | $379,899 | -20.3% | 23,863 | -18.1% | 0.06% | +16.7% |
| Q3 2022 | $476,747 | +140.8% | 29,141 | +107.1% | 0.05% | +84.6% |
| Q2 2022 | $198,000 | -17.5% | 14,070 | +42.1% | 0.03% | -52.7% |
| Q1 2022 | $240,000 | +3.0% | 9,901 | -1.0% | 0.06% | 0.0% |
| Q4 2021 | $233,000 | – | 9,999 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |